{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:36:38Z","timestamp":1761100598513,"version":"build-2065373602"},"reference-count":37,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T00:00:00Z","timestamp":1037318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The objective of this analysis was to evaluate the role of autologous stem cell transplantation (ASCT) in prolonging disease free survival (DFS) and overall survival (OS) in patients with chronic myeloid leukemia (CML) who received autografts of Philadelphia chromosome (Ph) positive or Ph negative cell harvests.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Over a 4\u2010year period (1994\u20131999), 53 patients who underwent ASCT for CML were reported to the Argentine Group of Bone Marrow Transplantation (GATMO) Registry.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Ph negative cell products were harvested in only 18 patients (34%). Comparison of disease status at the time of autograft, duration of neutropenia, thrombocytopenia, days of antibiotics, and transfusional requirements of red blood cells and platelets did not reveal statistical significant differences between the Ph positive group and the Ph negative group. Only days of hospitalization were increased significantly in patients who received Ph positive autografts. Although DFS at 36 months was significantly longer after infusion of Ph negative cell products (54% vs. 14%; <jats:italic>P<\/jats:italic> \u2264 0.005), OS differences between the Ph negative group and the Ph positive group (68% vs. 53%; <jats:italic>P<\/jats:italic> \u2264 0.134) were not significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>ASCT with Ph negative cell harvests after myeloablative chemotherapy resulted in prolonged periods of hematologic and cytogenetic remission or stable disease after cytogenetic\/molecular recurrence in some patients with CML. A superior DFS was observed without any benefit observed for OS. Cancer 2002;95:2339\u201345. \u00a9 2002 American Cancer Society.<\/jats:p><jats:p>DOI 10.1002\/cncr.10931<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.10931","type":"journal-article","created":{"date-parts":[[2002,11,18]],"date-time":"2002-11-18T08:42:32Z","timestamp":1037608952000},"page":"2339-2345","source":"Crossref","is-referenced-by-count":5,"title":["Autologous stem cell transplantation for patients with chronic myeloid leukemia"],"prefix":"10.1002","volume":"95","author":[{"given":"Benjam\u00edn","family":"Koziner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Dengra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"C\u00e1nepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Milovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Milone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anibal","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ider","family":"Cerutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Saporito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Kusminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Milone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Bordone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Lastiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,11,19]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80007-8"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401706"},{"key":"e_1_2_5_4_2","first-page":"1517","article-title":"An evidence\u2010based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology","volume":"94","author":"Silver RT","year":"1999","journal-title":"Blood."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.7.2039"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-4-199502150-00003"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.21.1616"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.284"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V73.4.861.861","article-title":"Indications for marrow transplantation in chronic myelogenous leukemia","volume":"73","author":"Thomas DE","year":"1989","journal-title":"Blood."},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804023381405"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V95.7.2219","article-title":"Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program","volume":"95","author":"McGlave PB","year":"2000","journal-title":"Blood."},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199209061566"},{"key":"e_1_2_5_13_2","first-page":"267","article-title":"Collection of \u201cnormal\u201d blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia","volume":"12","author":"Carella AM","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910615)67:12<2959::AID-CNCR2820671203>3.0.CO;2-T"},{"key":"e_1_2_5_15_2","first-page":"407","article-title":"Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation","volume":"14","author":"Reiffers J","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92589-5"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood.V89.8.2623","article-title":"Autologous transplantation therapy for chronic myelogenous leukemia","volume":"89","author":"Bhatia R","year":"1997","journal-title":"Blood."},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.553"},{"key":"e_1_2_5_19_2","first-page":"201","article-title":"High\u2010dose chemo\u2010radiotherapy followed by autologous Philadelphia chromosome\u2010negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia","volume":"17","author":"Carella AM","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.3.724.724"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700908"},{"key":"e_1_2_5_22_2","first-page":"425","article-title":"Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide","volume":"14","author":"Carlo\u2010Stella C","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.4.1150"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood.V93.5.1534","article-title":"Autografting with Philadelphia chromosome\u2010negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia","volume":"93","author":"Carella AM","year":"1999","journal-title":"Blood."},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00897.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709058307"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703057"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/14653240152584695"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.6.1905.1905"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441401"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011573"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03030-X"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701891"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.5.1820"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109057949"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809059255"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03600.x"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.10931","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.10931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T18:34:02Z","timestamp":1760294042000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.10931"}},"subtitle":["The Argentine Group of Bone Marrow Transplantation (GATMO) experience"],"short-title":[],"issued":{"date-parts":[[2002,11,19]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1002\/cncr.10931"],"URL":"https:\/\/doi.org\/10.1002\/cncr.10931","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2002,11,19]]}}}